Two Sigma Advisers’s Cellectis CLLS Stock Holding History

Two Sigma Advisers’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,900	Closed	-$34K	–	2534
2022 Q3	$34K	Sell	14,900 -400	-3%	-$1.21K	﹤0.01%	2403
2022 Q2	$43K	Sell	15,300 -39,500	-72%	-$139K	﹤0.01%	2492
2022 Q1	$249K	Buy	+54,800	New	+$302K	﹤0.01%	2306
2021 Q2	–	Sell	-17,912	Closed	-$362K	–	2477
2021 Q1	$362K	Buy	+17,912	New	+$443K	﹤0.01%	2151
2020 Q3	–	Sell	-11,112	Closed	-$198K	–	2428
2020 Q2	$198K	Buy	+11,112	New	+$169K	﹤0.01%	2249
2018 Q3	–	Sell	-11,800	Closed	-$334K	–	2255
2018 Q2	$334K	Buy	+11,800	New	+$351K	﹤0.01%	2064

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Advisers's CLLS Position: Q4 2022 in Review

Two Sigma Advisers sold out of Cellectis (CLLS) in Q4 2022, closing a stake of 14,900 shares — an estimated $34K sold.

Two Sigma Advisers first reported a position in CLLS in Q2 2018 and held it in 6 quarters. The position peaked at $362K in Q1 2021. 40 funds tracked by Wall St. Rank hold CLLS as of Q4 2022.

Two Sigma Advisers reported no remaining Cellectis position as of Q4 2022 after selling out during the quarter.
Two Sigma Advisers sold 14,900 Cellectis shares in Q4 2022, an estimated $34K.
Two Sigma Advisers first reported a position in Cellectis in Q2 2018 and held it in 6 quarters.
Two Sigma Advisers's Cellectis position peaked at $362K in Q1 2021.
40 funds tracked by Wall St. Rank held Cellectis as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.